Trodelvy Improves Survival for Patients with HR2+/HER- Breast Cancer
- Care For A Cure
- Aug 28, 2023
- 1 min read
Treatment with Trodelvy (sacituzumab govitecan) significantly improved survival among some patients with breast cancer, according to the findings of a recent international trial.

תגובות